... needn't worry that it will burn through its cash any time soon. Biotech investing remains risky, and stem cell research doubly so. The short story here seems to have been based on misinformation and with the biotech forcefully answering the ...
http://www.fool.com/investing/general/2012/11/29/are-short-sellers-onto-something-at-pluristem-ther.aspx
http://www.fool.com/investing/general/2012/11/29/are-short-sellers-onto-something-at-pluristem-ther.aspx
No comments:
Post a Comment